Renaissance Capital logo

DMB Acquisition Withdrawn, Nasdaq: LSAC

Third blank check company formed by LifeSci Capital targeting the healthcare industry.

Industry: SPAC

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: SPAC

We are a blank check company. Although there is no restriction or limitation on what industry our target operates in, it is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America or Europe that are developing assets in the biopharma, medical technology, digital health, and healthcare services sectors, which aligns with our management team’s experience in healthcare investing and drug development. At the time of preparing this prospectus, we have not identified any specific business combination, nor has anyone on our behalf initiated or engaged in any substantive discussions, formal or otherwise, related to such a transaction. Our efforts to date are limited to organizational activities related to this offering. However, our management team had been actively in discussions with potential business combination partners in their capacity as officers of LifeSci Acquisition II Corp., a special purpose acquisition company, and we may pursue business combination partners that had previously been in discussions with LifeSci Acquisition II Corp.’s management team.
more less
IPO News for DMB Acquisition
more
IPO Data
IPO File Date 07/30/2021
Offer Price
Price Range $10.00 - $10.00
Offer Shares (mm) 7.5
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date
Offer Price
Price Range $10.00 - $10.00
Offer Shares (mm) 7.5
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters New York, NY
Founded 2019
Employees 2
Website www.lifescicapital.com